BioStem Technologies Inc
PublicBioStem Technologies Inc is now publicly traded
The data on this page reflects BioStem Technologies Inc's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Early Stage
VC
Sep 21, 2026
Total Funding Raised
$2.5M
Company Overview
BioStem Technologies Inc is a regenerative medicine company that develops, manufactures, and commercializes placental-derived allografts for advanced wound care and surgical applications.
Sector
Healthcare
AI Layer
Non-AI
Keywords
BioStem Technologies Inc Comparables
Compare BioStem Technologies Inc with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Skye Biologics Holdings | 86% | |
| Merakris Therapeutics | 75% | |
| CTM Biomedical | 75% |
BioStem Technologies Inc Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Stage VC | Sep 21, 2026 | ||||
| Private Placement | Jun 3, 2026 |
Key People
Founding team and executive leadership
BioStem Technologies Inc Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access